Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers

Journal: Nature Communications

Published: 2020-07-03

DOI: 10.1038/s41467-020-16483-3

Affiliations: 75

Authors: 199

Go to article
Institutions Share
NIH NCI Division of Cancer Epidemiology and Genetics (DCEG), United States of America (USA) 0.10
ICR Division of Genetics and Epidemiology, United Kingdom (UK) 0.05
WHO International Agency for Research on Cancer (IARC), France 0.05
Centre for Cancer Genetic Epidemiology (CCGE), University of Cambridge, United Kingdom (UK) 0.05
Department of Cancer Epidemiology, MOFFITT, United States of America (USA) 0.04
Public Health Sciences Division (PHS), FHCRC, United States of America (USA) 0.04
Behavioral and Epidemiology Research Group (BERG), ACS, United States of America (USA) 0.04
QIMR Berghofer Statistical Genetics Laboratory, Australia 0.03
Mayo Clinic Division of Epidemiology, United States of America (USA) 0.03
Centre for Epidemiology and Biostatistics, UniMelb, Australia 0.02
UCSF Department of Neurological Surgery, United States of America (USA) 0.02
Division of Clinical Epidemiology and Aging Research, DKFZ, Germany 0.02
QIMR Berghofer Department of Genetics and Computational Biology, Australia 0.02
USC Norris Comprehensive Cancer Center, United States of America (USA) 0.02
USC Department of Preventive Medicine, United States of America (USA) 0.02
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA) 0.02
Division of Cancer Medicine, MD Anderson Cancer Center, United States of America (USA) 0.02
Department of Medical Epidemiology and Biostatistics (MEB), KI, Sweden 0.02
Yale Department of Chronic Disease Epidemiology (CDE), United States of America (USA) 0.02
NIH NCI Laboratory of Translational Genomics, United States of America (USA) 0.02
Department of Medical Oncology, DFCI, United States of America (USA) 0.02
Lunenfeld-Tanenbaum Research Institute (LTRI), U of T, Canada 0.02
Case Comprehensive Cancer Center (Case CCC), CWRU, United States of America (USA) 0.01
Dan L. Duncan Comprehensive Cancer Center, United States of America (USA) 0.01
Institute for Clinical and Translational Research (ICTR), BCM, United States of America (USA) 0.01
Faculty of Medicine, UMU, Sweden 0.01
Cancer Registry of Norway (CRN), Norway 0.01
Department of Population and Quantitative Health Sciences, CWRU, United States of America (USA) 0.01
NIH NCI Clinical Genetics Branch (CGB), United States of America (USA) 0.01
Division of Hematology and Hematologic Malignancies, Utah, United States of America (USA) 0.01
Harvard T.H. Chan School of Public Health, United States of America (USA) 0.01
Mayo Clinic Division of Biomedical Statistics and Informatics, United States of America (USA) 0.01
Margaret M. and Albert B. Alkek Department of Medicine, BCM, United States of America (USA) 0.01
Duke School of Medicine, United States of America (USA) 0.01
Cedars-Sinai Center for Bioinformatics and Functional Genomics, United States of America (USA) 0.01
Rollins School of Public Health (RSPH), Emory University, United States of America (USA) 0.01
Department of Cancer Prevention and Control, RPCI, United States of America (USA) 0.01
Division of Translational Medicine and Human Genetics, Penn Medicine, United States of America (USA) 0.01
Section of Epidemiology and Biostatistics, University of Leeds, United Kingdom (UK) 0.01
Centre for Genetic Origins of Health and Disease (GOHaD), Australia 0.01
Center for Public Health Genomics (CPHG), UVA, United States of America (USA) 0.01
Leeds Institute of Medical Research at St James's (LIMR), University of Leeds, United Kingdom (UK) 0.01
QIMR Berghofer Cancer Control Group, Australia 0.01
Centre Hospitalier de l’Université Laval (CHUL) Research Centre, UL, Canada 0.01
Department of Public Health Sciences, UVA, United States of America (USA) 0.01
Toxicology Pharmacology and Cellular Signaling, France 0.01
Division of Molecular Genetic Epidemiology, DKFZ, Germany 0.01
Harvard Medical School (HMS), United States of America (USA) 0.01
Channing Division of Network Medicine, BWH, United States of America (USA) 0.01
NIHR Oxford Biomedical Research Centre (OxBRC), United Kingdom (UK) 0.01
Institute of Cancer and Genomic Sciences, UB, United Kingdom (UK) 0.01
DTU Department of Health Technology (DTU Health Tech), Denmark 0.01
Department of Biostatistics, JHU, United States of America (USA) 0.01
Department of Cancer Epidemiology, UHH, Germany 0.01
Division of Cancer Epidemiology, DKFZ, Germany 0.01
Copenhagen University Hospital (CUH), Denmark 0.01
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Netherlands 0.01
Department of Clinical Neurosciences, University of Cambridge, United Kingdom (UK) 0.01
Department of Oncology, Stockholm South General Hospital, Sweden 0.01
Cancer Epidemiology Division (CED), Cancer Council Victoria, Australia 0
School of Clinical Sciences (SCS), Monash University, Australia 0
Department of Epidemiology, U-M, United States of America (USA) 0
Department of Electron Microscopy and Molecular Pathology, CING, Cyprus 0
Cyprus School of Molecular Medicine (CSMM), CING, Cyprus 0
Harvard Department of Epidemiology, United States of America (USA) 0
Division of Molecular Pathology, NKI, Netherlands 0
Division of Psychosocial Research and Epidemiology, NKI, Netherlands 0
Li Ka Shing Faculty of Medicine, HKU, China 0
UNC Department of Epidemiology, United States of America (USA) 0
Department of Statistics and Actuarial Science, HKU, China 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER